World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
100
Citations
49285
World Ranking
715
National Ranking
408

Medicine

D-Index
101
Citations
49833
World Ranking
7837
National Ranking
4084

Israel F. Charo publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Israel F. Charo sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 201 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Israel F. Charo D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Israel F. Charo sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 100 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Israel F. Charo is affiliated with the University of California, San Francisco in the United States. Their research spans several fields within biomedical sciences, with a significant focus on medicine, biochemistry, genetics, and molecular biology.

Their primary fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these domains, Charo has contributed notably to several subfields, namely:

  • Immunology
  • Molecular Biology
  • Oncology
  • Cardiology and Cardiovascular Medicine
  • Dermatology

The scientist's main research topics comprise:

  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Signaling Pathways in Disease
  • Cardiac Fibrosis and Remodeling
  • Immune Cell Function and Interaction
  • Hidradenitis Suppurativa and Treatments
  • Chemokine receptors and signaling

Israel F. Charo has published numerous papers in renowned venues. Some of their recent publications include:

  • CCR2 deficiency alters activation of microglia subsets in traumatic brain injury, 2021, Cell Reports
  • Chromatin remodelling drives immune cell-fibroblast communication in heart failure, 2024, Nature
  • Chromatin Remodeling Drives Immune-Fibroblast Crosstalk in Heart Failure Pathogenesis, 2023, bioRxiv (Cold Spring Harbor Laboratory)
  • CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity, 2023, PLoS ONE
  • Chemokine receptors (version 2020.5) in the IUPHAR/BPS Guide to Pharmacology Database, 2020, IUPHAR/BPS Guide to Pharmacology CITE

Frequent coauthors of Charo include:

  • Thomas J. Schall
  • Linda Ertl
  • Kathleen M. Sullivan
  • Carolyn Dunlap
  • Zhenhua Miao

Their work appears repeatedly in specific scientific journals and domains, as reflected in these frequent publication venues:

  • IUPHAR/BPS Guide to Pharmacology CITE
  • Cancer Research
  • Nephrology Dialysis Transplantation
  • Journal of Investigative Dermatology
  • Journal of the American Society of Nephrology

Among the recognitions awarded, Charo is a member of the Association of American Physicians.

Best Publications

  • The Many Roles of Chemokines and Chemokine Receptors in Inflammation

    Israel F. Charo;Richard M. Ransohoff

  • Decreased lesion formation in CCR2 −/− mice reveals a role for chemokines in the initiation of atherosclerosis

    Landin Boring;Jennifa Gosling;Michael Cleary;Israel F. Charo

  • International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors

    Philip M. Murphy;Marco Baggiolini;Israel F. Charo;Caroline A. Hébert

  • CCR2 modulates inflammatory and metabolic effects of high-fat feeding

    Stuart P. Weisberg;Deborah Hunter;Reid Huber;Jacob Lemieux

  • Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice.

    Landin Boring;Jennifa Gosling;Stephen W. Chensue;Steven L. Kunkel

  • The platelet membrane glycoprotein IIb-IIIa complex

    D. R. Phillips;I. F. Charo;Leslie V Parise;L. A. Fitzgerald

  • Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites

    Chia-Lin Tsou;Wendy Peters;Yue Si;Sarah Slaymaker

  • Langerhans cells renew in the skin throughout life under steady-state conditions

    Miriam Merad;Markus G. Manz;Holger Karsunky;Amy Wagers

  • Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails.

    Israel F. Charo;Scott J. Myers;Ann Herman;Christian Franci

  • Chemokines in the Pathogenesis of Vascular Disease

    Israel F. Charo;Mark B. Taubman

  • MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B

    Jennifa Gosling;Sarah Slaymaker;Long Gu;Susan Tseng

  • Differential roles of microglia and monocytes in the inflamed central nervous system.

    Ryo Yamasaki;Haiyan Lu;Oleg Butovsky;Nobuhiko Ohno

  • Domains specifying thrombin-receptor interaction.

    Thien-Khai H. Vu;Virginia I. Wheaton;David T. Hung;Israel Charo

  • Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice.

    Noah Saederup;Astrid E. Cardona;Kelsey Croft;Makiko Mizutani

  • Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2)

    Leonid Izikson;Robyn S. Klein;Israel F. Charo;Howard L. Weiner

  • GPIIb-IIIa: the responsive integrin.

    David R. Phillips;Israel F. Charo;Robert M. Scarborough

  • Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha.

    Carol J. Raport;Jennifa Gosling;Vicki L. Schweickart;Patrick W. Gray

  • Resolving postoperative neuroinflammation and cognitive decline

    Niccolò Terrando;Lars I Eriksson;Lars I Eriksson;Jae Kyu Ryu;Ting Yang

  • Decreased atherosclerosis in CX3CR1–/– mice reveals a role for fractalkine in atherogenesis

    Philippe Lesnik;Christopher A. Haskell;Israel F. Charo

  • Notch2 Receptor Signaling Controls Functional Differentiation of Dendritic Cells in the Spleen and Intestine

    Kanako L. Lewis;Michele L. Caton;Milena Bogunovic;Melanie Greter

Frequent Co-Authors

Thomas J. Schall
Thomas J. Schall ChemoCentryx (United States)
Richard M. Ransohoff
Richard M. Ransohoff Harvard University
Barrett J. Rollins
Barrett J. Rollins Brigham and Women's Hospital
Andrew D. Luster
Andrew D. Luster Harvard University
Kensuke Egashira
Kensuke Egashira Kyushu University
Mark A. Goldsmith
Mark A. Goldsmith Revolution Medicines
Sergio A. Lira
Sergio A. Lira Icahn School of Medicine at Mount Sinai
Steven L. Kunkel
Steven L. Kunkel University of Michigan–Ann Arbor
Shaun R. Coughlin
Shaun R. Coughlin University of California, San Francisco
Christophe Combadière
Christophe Combadière Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can broaden career options. Nursing programs, particularly Nurse Practitioner degrees, offer pathways that integrate immunological knowledge with clinical practice. Many students seek the easiest nurse practitioner program to efficiently transition into advanced practice roles.

Specializations like Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs are also popular. These programs emphasize mental health and immunological responses, with some schools offering strong support through the top online pmhnp programs with best clinical placement rates. Choosing reputable programs improves hands-on learning experiences, crucial for career success.

Affordability remains a major concern for many students. For those balancing budget constraints, the cheapest online pmhnp programs provide cost-effective education without compromising quality. Financial considerations often guide decisions on which degree pathway to pursue.

Graduates holding advanced degrees can expect competitive salaries. According to recent data on doctorate in nursing salary, compensation varies by location and specialization, making it important to research salary trends during career planning.

Best Scientists Citing Israel F. Charo

Trending Scientists

Recently Published Articles